Partner Content Partner Content SMi’s Drug Discovery Chemistry announces key industry speake... SMi’s Drug Discovery Chemistry brochure available
Partner Content Partner Content 3rd Microbiome Movement - Drug Development Europe New Speakers: Microbiome Drug Development Europe Summit
Events Partner Content 3rd Microbiome Movement - Drug Development Europe Recent breakthroughs in DNA sequencing, metagenomic analysis and computational techniques have given scientists new insight into the structure and function of the human microbiota, an interconnecte
Partner Content Partner Content Regulatory Issues for PF Syringes & Injectable Drug Devi... Pre-Filled Syringes & Injectable Drug Devices Europe
Partner Content Partner Content Preliminary Attendee List Released for Orphan Drugs & Rare D... Attendees Released for Orphan Drugs & Rare Diseases
Partner Content Partner Content SMi’s release speaker interview Anita Burrell, speaker at Bi... Biosimilars USA conference information
News Alzheimer's biotech Korsana to go public via reverse merger By merging with Cyclerion, Korsana will get a Nasdaq listing and additional cash to develop its new-generation amyloid-targeting drug for Alzheimer's.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
